1,992
Views
3
CrossRef citations to date
0
Altmetric
HPV – Research Article

HPV vaccine intention among university students during suspension of active recommendation in Japan

, , , , , , , , , , & show all
Article: 2116900 | Received 01 Jun 2022, Accepted 20 Aug 2022, Published online: 15 Sep 2022

References

  • Lei J, Ploner A, Elfström KM, Wang J, Roth A, Fang F, Sundström K, Dillner J, Sparén P. HPV vaccination and the risk of invasive cervical cancer. N Engl J Med. [Internet] 2020;383(14):1–9. [accessed 2022 Mar 31] https://www.nejm.org/doi/full/10.1056/NEJMoa1917338
  • Bray F, Ferlay J, Laversanne M, Brewster DH, Gombe Mbalawa C, Kohler B, Piñeros M, Steliarova-Foucher E, Swaminathan R, Antoni S, et al. Cancer incidence in five continents: inclusion criteria, highlights from volume X and the global status of cancer registration. Int J Cancer [Internet]. 2015;137(9):2060–2071. [accessed 2022 May 9] doi:10.1002/ijc.29670.
  • Drolet M, Bénard É, Boily MC, Ali H, Baandrup L, Bauer H, Beddows S, Brisson J, Brotherton JML, Cummings T, et al. Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis. Lancet Infect Dis [Internet]. 2015;15(5):565–580. [accessed 2022 Mar 31] doi:10.1016/S1473-3099(14)71073-4.
  • Drolet M, Bénard É, Pérez N, Brisson M, Ali H, Boily MC, Baldo V, Brassard P, Brotherton JML, Callander D, et al. Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis. Lancet (London, England) [Internet] 2019; 394:497–509. [accessed 2022 Mar 31] https://pubmed.ncbi.nlm.nih.gov/31255301/
  • Patel C, Brotherton JML, Pillsbury A, Jayasinghe S, Donovan B, Macartney K, Marshall H. The impact of 10 years of human papillomavirus (HPV) vaccination in Australia: what additional disease burden will a nonavalent vaccine prevent? Euro Surveill [Internet]. 2018; 23:30–40. [accessed 2022 Mar 31] https://pubmed.ncbi.nlm.nih.gov/30326995/
  • Mehanna H, Bryant TS, Babrah J, Louie K, Bryant JL, Spruce RJ, Batis N, Olaleye O, Jones J, Struijk L, et al. Human Papillomavirus (HPV) vaccine effectiveness and potential herd immunity for reducing oncogenic oropharyngeal HPV-16 prevalence in the United Kingdom: a cross-sectional study. Clin Infect Dis [Internet]. 2019;69(8):1296–1302. [accessed 2022 Mar 31] doi:10.1093/cid/ciy1081.
  • Cameron RL, Kavanagh K, Pan J, Love J, Cuschieri K, Robertson C, Ahmed S, Palmer T, Pollock KGJ. Human papillomavirus prevalence and herd immunity after introduction of vaccination program, Scotland, 2009–2013. Emerg Infect Dis [Internet]. 2016; 22(1):56–64. [accessed 2022 Jan 11] doi:10.3201/eid2201.150736.
  • Schlecht NF, Diaz A, Nucci-Sack A, Shyhalla K, Shankar V, Guillot M, Hollman D, Strickler HD, Burk RD. Incidence and types of human papillomavirus infections in adolescent girls and young women immunized with the human papillomavirus vaccine. JAMA Netw Open [Internet]. 2021; 4(8):e2121893. [accessed 2022 Mar 31] doi:10.1001/jamanetworkopen.2021.21893.
  • Berenson AB, Hirth JM, Chang M. Change in human papillomavirus prevalence among U.S. women aged 18–59 years, 2009–2014. Obstet Gynecol [Internet]. 2017;130(4):693–701. [accessed 2022 Jan 11] doi:10.1097/AOG.0000000000002193.
  • Vänskä S, Luostarinen T, Lagheden C, Eklund C, Kleppe SN, Andrae B, Sparén P, Sundström K, Lehtinen M, Dillner J. Differing age-specific cervical cancer incidence between different types of human papillomavirus: implications for predicting the impact of elimination programs. Am J Epidemiol [Internet]. 2021; 190(4):506–514. [accessed 2022 Mar 31] doi:10.1093/aje/kwaa121.
  • Kjaer SK, Nygård M, Sundström K, Munk C, Berger S, Dzabic M, Fridrich KE, Waldstrøm M, Sørbye SW, Bautista O, et al. Long-term effectiveness of the nine-valent human papillomavirus vaccine in Scandinavian women: interim analysis after 8 years of follow-up. Hum Vaccin Immunother [Internet]. 2021; 17(4):943. [accessed 2022 Mar 31]doi:10.1080/21645515.2020.1839292.
  • Hanley SJB, Yoshioka E, Ito Y, Kishi R. HPV vaccination crisis in Japan. Lancet (London, England) [Internet]. 2015;385:2571. [accessed 2022 Jan 11] https://pubmed.ncbi.nlm.nih.gov/26122153/
  • Cancer Statistics in Japan. Table download [Internet]. [accessed 2022 Mar 31]. https://ganjoho.jp/reg_stat/statistics/data/dl/en.html
  • Tanaka Y, Ueda Y, Kishida H, Hosogai N, Morimoto A, Egawa-Takata T, Matsuzaki S, Kobayashi E, Yoshino K, Kimura T. Trends in the cervical cancer screening rates in a city in Japan between the years of 2004 and 2013. Int J Clin Oncol [Internet]. 2015; 20(6):1156–1160. [accessed 2022 Mar 31] doi:10.1007/s10147-015-0842-3.
  • Watson M, Saraiya M, Ahmed F, Cardinez CJ, Reichman ME, Weir HK, Richards TB. Using population-based cancer registry data to assess the burden of human papillomavirus-associated cancers in the United States: overview of methods. Cancer. 2021;113(S10):2841–2854. doi:10.1002/cncr.23758.
  • Saraiya M, Unger ER, Thompson TD, Lynch CF, Hernandez BY, Lyu CW, Steinau M, Watson M, Wilkinson EJ, Hopenhayn C, et al. US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines. JNCI J Natl Cancer Inst [Internet]. 2015;107:86. [accessed 2022 Jan 11] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4838063/
  • Sasidharanpillai S, Ravishankar N, Kamath V, Bhat PV, Bhatt P, Arunkumar G. Prevalence of human papillomavirus (HPV) DNA among men with oropharyngeal and anogenital cancers: a systematic review and meta-analysis. Asian Pac J Cancer Prev [Internet]. 2021;22(5):1351–1364. [accessed 2022 Mar 31] doi:10.31557/APJCP.2021.22.5.1351.
  • Quinn S, Goldman RD. Human papillomavirus vaccination for boys. Can Fam Physician [Internet]. 2015;61:43. [accessed 2022 Mar 31] /pmc/articles/PMC4301763/.
  • Chen MM, Mott N, Clark SJ, Harper DM, Shuman AG, Prince MEP, Dossett LA. HPV vaccination among young adults in the US. JAMA [Internet]. 2021;325:1673–1674. [accessed 2022 Jan 11] doi:10.1001/jama.2021.0725.
  • Ishikawa H, Nomura K, Sato M, Yano E. Developing a measure of communicative and critical health literacy: a pilot study of Japanese office workers. Health Promot Int [Internet]. 2008;23(3):269–274. [acessed 2022 Jan 11] doi:10.1093/heapro/dan017.
  • Hatabu A, Mao X, Zhou Y, Kawashita N, Wen Z, Ueda M, Takagi T, Tian YS. Knowledge, attitudes, and practices toward COVID-19 among university students in Japan and associated factors: an online cross-sectional survey. PLoS One [Internet]. 2020; 15(12):e0244350. [accessed 2022 July 8] https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0244350
  • Janz NK, Becker MH. The health belief model: a decade later. Health Educ Q [Internet]. 1984;11(1):1–47. [accessed 2022 Mar 1] doi:10.1177/109019818401100101.
  • Linares LO, Shankar V, Diaz A, Nucci-Sack A, Strickler HD, Peake K, Weiss J, Burk RD, Schlecht NF. Association between cumulative psychosocial risk and cervical human papillomavirus infection among female adolescents in a free vaccination program. J Dev Behav Pediatr [Internet]. 2015;36(8):620–627. [accessed 2022 July 9] doi:10.1097/DBP.0000000000000178.
  • Bursac Z, Gauss CH, Williams DK, Hosmer DW. Purposeful selection of variables in logistic regression. Source Code Biol Med [Internet]. 2008;3:1–8. [accessed 2022 July 8] https://scfbm.biomedcentral.com/articles/10.1186/1751-0473-3-17
  • Bendel RB, Afifi AA Comparison of stopping rules in forward “stepwise regression”. J Am Stast Assoc [Internet]. 2012; 72:46–53. [accessed 2022 July 8] https://www.tandfonline.com/doi/abs/10.1080/01621459.1977.10479905
  • Mickey RM, Greenland S. The impact of confounder selection criteria on effect estimation. Am J Epidemiol [Internet]. 1989;129(1):125–137. [accessed 2022 July 8] doi:10.1093/oxfordjournals.aje.a115101.
  • Wong LP. Knowledge and attitudes about HPV infection, HPV vaccination, and cervical cancer among rural Southeast Asian Women. Int J Behav Med [Internet]. 2011;18(2):105–111. [accessed 2022 Apr 9] doi:10.1007/s12529-010-9104-y.
  • Nomura K, Minamizono S, Maeda E, Kim R, Iwata T, Hirayama J, Ono K, Fushimi M, Goto T, Mishima K, et al. Cross-sectional survey of depressive symptoms and suicide-related ideation at a Japanese national university during the COVID-19 stay-home order. Environ Health Prev Med [Internet]. 2021;26:1–9. [accessed 2022 Feb 14] https://environhealthprevmed.biomedcentral.com/articles/10.1186/s12199-021-00953-1
  • Damgacioglu H, Sonawane K, Chhatwal J, Lairson DR, Clifford GM, Giuliano AR, Deshmukh AA. Long-Term impact of HPV vaccination and COVID-19 pandemic on oropharyngeal cancer incidence and burden among men in the USA: a modeling study. Lancet Reg Heal Am [Internet]. 2022;8. [accessed 2022 July 8] https://pubmed.ncbi.nlm.nih.gov/34927126/
  • Smith DL, Perkins RB. Low rates of HPV vaccination and cervical cancer screening: challenges and opportunities in the context of the COVID-19 pandemic. Prev Med (Baltim). 2022;159:107070. doi:10.1016/j.ypmed.2022.107070.
  • Dillard JP, Spear ME. Knowledge of human papillomavirus and perceived barriers to vaccination in a sample of US female college students. J Am Coll Health [Internet]. 2010;59(3):186–190. [accessed 2022 Apr 7] doi:10.1080/07448481.2010.493189.
  • Chiang VCL, Wong HT, Yeung PCA, Choi YK, Fok MSY, Mak OI, Wong HY, Wong KH, Wong SY, Wong YS, et al. Attitude, acceptability and knowledge of HPV vaccination among local university students in Hong Kong. Int J Environ Res Public Heal [Internet]. 2016;13(5):486. [accessed 2022 Jan 13] doi:10.3390/ijerph13050486.
  • Gerend MA, Barley J. Human papillomavirus vaccine acceptability among young adult men. Sex Transm Dis [Internet]. 2009;36(1):58–62. [accessed 2022 Jan 13] doi:10.1097/OLQ.0b013e31818606fc.
  • Holman DM, Benard V, Roland KB, Watson M, Liddon N, Stokley S. Barriers to human papillomavirus vaccination among US adolescents: a systematic review of the literature. JAMA Pediatr [Internet]. 2014;168(1):76–82. [accessed 2022 Feb 18] doi:10.1001/jamapediatrics.2013.2752.
  • Santhanes D, Yong CP, Yap YY, Saw PS, Chaiyakunapruk N, Khan TM. Factors influencing intention to obtain the HPV vaccine in South East Asian and Western Pacific regions: a systematic review and meta-analysis. Sci Rep [Internet]. 2018;8(1). [accessed 2022 Mar 1] doi:10.1038/s41598-018-21912-x.
  • Suzuki S, Hosono A. No association between HPV vaccine and reported post-vaccination symptoms in Japanese young women: results of the Nagoya study. Papillomavirus Res (Amsterdam, Netherlands) [Internet]. 2018;5:96–103. [accessed 2022 Jan 13] https://pubmed.ncbi.nlm.nih.gov/29481964/
  • Larson HJ. Japan’s HPV vaccine crisis: act now to avert cervical cancer cases and deaths. Lancet Public Heal [Internet]. 2020;5(4):e184–5.[accessed 2022 Jan 13] doi:10.1016/S2468-2667(20)30047-5.
  • Walters R, Leslie SJ, Polson R, Cusack T, Gorely T. Establishing the efficacy of interventions to improve health literacy and health behaviours: a systematic review. BMC Public Health [Internet]. 2020;20:1–17. [accessed 2022 Mar 1] https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-020-08991-0
  • Ishizaki Y, Gomi H. Human papillomavirus vaccination and postural tachycardia syndrome, deconditioning and exercise-induced hyperalgesia: an alternate interpretation of the reported adverse reactions. J Obstet Gynaecol Res [Internet]. 2020;46(5):678–683. [cited 2022 Mar 1] doi:10.1111/jog.14227.
  • Thomsen RW, Öztürk B, Pedersen L, Nicolaisen SK, Petersen I, Olsen J, Sørensen HT. Hospital records of pain, fatigue, or circulatory symptoms in girls exposed to human papillomavirus vaccination: cohort, self-controlled case series, and population time trend studies. Am J Epidemiol [Internet]. 2020;189(4):277–285. [accessed 2022 Mar 1] doi:10.1093/aje/kwz284.
  • Haruyama R, Obara H, Fujita N. Japan resumes active recommendations of HPV vaccine after 8·5 years of suspension. Lancet Oncol [Internet]. 2022;23(2):197–198. [accessed 2022 Mar 20] doi:10.1016/S1470-2045(22)00002-X.
  • Kinoshita T, Abe RT, Hineno A, Tsunekawa K, Nakane S, Ikeda SI. Peripheral sympathetic nerve dysfunction in adolescent Japanese girls following immunization with the human papillomavirus vaccine. Intern Med [Internet]. 2014;53(19):2185–2200. [accessed 2022 Mar 1] doi:10.2169/internalmedicine.53.3133.
  • Ministry of Health Labour and Welfare. The 50th meeting of the subcommittee on vaccination of the health sciences council, subcommittee on adverse reactions. [Internet]. 2020 [accessed 2022 Feb 18]. https://www.mhlw.go.jp/stf/newpage_16556.html
  • Kling KC, Hyde JS, Showers CJ, Buswell BN. Gender differences in self-esteem: a meta-analysis. Psychol Bull [Internet]. 1999;125(4):470–500. [accessed 2022 Mar 1] doi:10.1037/0033-2909.125.4.470.
  • Nomura K, Yano E, Fukui T. Gender differences in clinical confidence: a nationwide survey of resident physicians in Japan. Acad Med [Internet] 2010;85(4):647–653. [accessed 2022 Jan 13] doi:10.1097/ACM.0b013e3181d2a796.
  • Kukulu K, Korukcu O, Ozdemir Y, Bezci A, Calik C. Self-confidence, gender and academic achievement of undergraduate nursing students. J Psychiatr Ment Health Nurs [Internet]. 2013;20(4):330–335. [accessed 2022 Jan 13] doi:10.1111/j.1365-2850.2012.01924.x.
  • Magnus JR, Peresetsky AA. Grade expectations: rationality and overconfidence. Front Psychol [Internet]. 2018;8. [accessed 2022 Jan 13] doi:10.3389/fpsyg.2017.02346.
  • Rad MK, Fakhri A, Stein LAR, Araban M. Health-Care staff beliefs and coronavirus disease 2019 vaccinations: a cross-sectional study from Iran. Asian J Soc Heal Behav [Internet]. 2022;5(1):40. [accessed 2022 July 5] doi:10.4103/shb.shb_13_22.